MELTZER LESLIE
CIK 2084030
Transactions on file
8
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | Disp. | 45,220 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | Disp. | 61,804 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | Disp. | 45,220 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | Grant | 45,220 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | Disp. | 22,610 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | Grant | 22,610 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Research and Development | U | 107,024 | $0.00 | — | open → |
| 2025-09-02 | 2025-08-26 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Research and Development | Grant | 61,804 | $0.00 | — | open → |
